1700016J18Rik Activators are an array of chemical compounds that indirectly stimulate the functional activity of 1700016J18Rik via distinct signaling pathways. Forskolin, by raising intracellular cAMP levels, indirectly heightens 1700016J18Rik's functional role by driving PKA activation, which can phosphorylate various substrates that may interface with 1700016J18Rik, thus enhancing its activity. PMA, through PKC activation, and Ionomycin, by bolstering intracellular calcium, can both instigate pathways that lead to post-translational modifications of proteins in proximity to 1700016J18Rik, potentially heightening its functional state. Sphingosine-1-phosphate and Epigallocatechin gallate (EGCG) work via distinct receptor-mediated and kinase inhibition routes, respectively, to potentiate cellular processes that can upregulate the activity of 17000161700016J18Rik Activators encompass a suite of chemical entities that indirectly potentiate the functional activity of 1700016J18Rik through diverse biochemical signaling cascades. Forskolin, a known adenylyl cyclase activator, leads to elevated cAMP levels within cells, thereby activating protein kinase A (PKA).
Activated PKA is capable of phosphorylating a myriad of substrates, some of which may be involved in the regulation or activity enhancement of 1700016J18Rik. Similarly, PMA, an activator of protein kinase C (PKC), might phosphorylate regulatory proteins that interact with 1700016J18Rik, leading to its enhanced activity. Ionomycin, by increasing intracellular calcium levels, and Sphingosine-1-phosphate, which signals through its specific G protein-coupled receptors, are both capable of initiating signaling cascades that result in the activation of calcium-dependent kinases or other modulatory proteins that can indirectly increase the activity of 1700016J18Rik through phosphorylation or other post-translational modifications. Furthermore, the activity of 1700016J18Rik is influenced by a spectrum of kinase modulators; EGCG, a polyphenol compound, inhibits specific kinases that may otherwise negatively regulate 1700016J18Rik, thereby enhancing its activity through relief of inhibition.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC, which could phosphorylate proteins that regulate 1700016J18Rik's activity, thereby enhancing its functional role. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium, potentially activating calcium-dependent kinases that interact with 1700016J18Rik, leading to its activation. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Binds to S1P receptors, potentially initiating signaling cascades that culminate in the activation of 1700016J18Rik through post-translational modifications. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Inhibits certain kinases, possibly reducing negative regulatory influences on 1700016J18Rik, thereby enhancing its activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, altering signaling pathways and potentially upregulating pathways that activate 1700016J18Rik through indirect mechanisms. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, possibly shifting signaling dynamics to favor the activation of 1700016J18Rik through alternative pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Increases intracellular calcium levels, which may activate 1700016J18Rik directly or through calcium-sensitive signaling mechanisms. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Inhibits tyrosine kinases, potentially alleviating inhibitory phosphorylation on pathways that activate 1700016J18Rik. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, which might lead to an upregulation of alternative pathways that enhance the activity of 1700016J18Rik. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A broad-spectrum kinase inhibitor that may non-selectively activate 1700016J18Rik by inhibiting kinases that negatively regulate it. | ||||||